Will Biogen’s Alzheimer’s Drug – Aduhelm Help with Dementia Treatment?

June 13, 2021

FDA endorsement of Biogen’s Alzheimer’s drug Aduhelm has triggered a major debate in dementia treatment.More than 6 million Americans are affected by Alzheimer’s or other dementias, the sixth-leading cause of death in the U.S.. By some professional estimates, the number of sufferers could, unfortunately, double in the decades ahead. Several high-profile FDA panel advisors quit after the controversial Biogen drug approval, which could generate billions of dollars in sales. Still,…

Read More >>